Annual CFO
-$300.32 M
-$70.83 M-30.86%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual cash flow from operations is -$300.32 million, with the most recent change of -$70.83 million (-30.86%) on December 31, 2023.
- During the last 3 years, RLAY annual CFO has fallen by -$197.83 million (-193.02%).
- RLAY annual CFO is now -580.45% below its all-time high of -$44.13 million, reached on December 31, 2018.
Performance
RLAY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$75.08 M
-$9.25 M-14.05%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly cash flow from operations is -$75.08 million, with the most recent change of -$9.25 million (-14.05%) on September 1, 2024.
- Over the past year, RLAY quarterly CFO has increased by +$314.00 thousand (+0.42%).
- RLAY quarterly CFO is now -260.98% below its all-time high of $46.64 million, reached on March 31, 2021.
Performance
RLAY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$280.43 M
+$314.00 K+0.11%
September 1, 2024
Summary
- As of February 7, 2025, RLAY TTM cash flow from operations is -$280.43 million, with the most recent change of +$314.00 thousand (+0.11%) on September 1, 2024.
- Over the past year, RLAY TTM CFO has dropped by -$12.22 million (-4.56%).
- RLAY TTM CFO is now -2492.71% below its all-time high of -$10.82 million, reached on March 31, 2019.
Performance
RLAY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RLAY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.9% | +0.4% | -4.6% |
| 3 y3 years | -193.0% | -41.1% | -300.8% |
| 5 y5 years | -580.5% | -329.0% | -324.0% |
RLAY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -303.6% | at low | -89.1% | +15.8% | -276.9% | +6.6% |
| 5 y | 5-year | -354.1% | at low | -261.0% | +15.8% | -736.7% | +6.6% |
| alltime | all time | -580.5% | at low | -261.0% | +15.8% | -2492.7% | +6.6% |
Relay Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$75.08 M(+14.1%) | -$280.43 M(-0.1%) |
| Jun 2024 | - | -$65.83 M(+30.8%) | -$280.74 M(-1.0%) |
| Mar 2024 | - | -$50.32 M(-43.6%) | -$283.51 M(-5.6%) |
| Dec 2023 | -$300.32 M(+30.9%) | -$89.19 M(+18.3%) | -$300.32 M(+12.0%) |
| Sep 2023 | - | -$75.40 M(+9.9%) | -$268.21 M(+3.6%) |
| Jun 2023 | - | -$68.60 M(+2.2%) | -$258.95 M(+4.7%) |
| Mar 2023 | - | -$67.13 M(+17.6%) | -$247.45 M(+7.8%) |
| Dec 2022 | -$229.49 M(+208.4%) | -$57.08 M(-13.7%) | -$229.49 M(+8.2%) |
| Sep 2022 | - | -$66.14 M(+15.9%) | -$212.12 M(+6.5%) |
| Jun 2022 | - | -$57.09 M(+16.1%) | -$199.17 M(+17.0%) |
| Mar 2022 | - | -$49.17 M(+23.8%) | -$170.22 M(+128.8%) |
| Dec 2021 | -$74.41 M | -$39.71 M(-25.4%) | -$74.41 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$53.20 M(+89.1%) | -$69.97 M(+71.5%) |
| Jun 2021 | - | -$28.14 M(-160.3%) | -$40.81 M(+21.8%) |
| Mar 2021 | - | $46.64 M(-232.2%) | -$33.52 M(-67.3%) |
| Dec 2020 | -$102.49 M(+55.0%) | -$35.27 M(+46.7%) | -$102.49 M(+13.9%) |
| Sep 2020 | - | -$24.04 M(+15.3%) | -$89.98 M(+7.8%) |
| Jun 2020 | - | -$20.84 M(-6.7%) | -$83.44 M(+7.5%) |
| Mar 2020 | - | -$22.33 M(-1.9%) | -$77.65 M(+17.4%) |
| Dec 2019 | -$66.13 M(+49.8%) | -$22.76 M(+30.0%) | -$66.13 M(+52.5%) |
| Sep 2019 | - | -$17.50 M(+16.3%) | -$43.37 M(+67.7%) |
| Jun 2019 | - | -$15.05 M(+39.2%) | -$25.87 M(+139.2%) |
| Mar 2019 | - | -$10.82 M | -$10.82 M |
| Dec 2018 | -$44.13 M | - | - |
FAQ
- What is Relay Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Relay Therapeutics?
- What is Relay Therapeutics annual CFO year-on-year change?
- What is Relay Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Relay Therapeutics?
- What is Relay Therapeutics quarterly CFO year-on-year change?
- What is Relay Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Relay Therapeutics?
- What is Relay Therapeutics TTM CFO year-on-year change?
What is Relay Therapeutics annual cash flow from operations?
The current annual CFO of RLAY is -$300.32 M
What is the all time high annual CFO for Relay Therapeutics?
Relay Therapeutics all-time high annual cash flow from operations is -$44.13 M
What is Relay Therapeutics annual CFO year-on-year change?
Over the past year, RLAY annual cash flow from operations has changed by -$70.83 M (-30.86%)
What is Relay Therapeutics quarterly cash flow from operations?
The current quarterly CFO of RLAY is -$75.08 M
What is the all time high quarterly CFO for Relay Therapeutics?
Relay Therapeutics all-time high quarterly cash flow from operations is $46.64 M
What is Relay Therapeutics quarterly CFO year-on-year change?
Over the past year, RLAY quarterly cash flow from operations has changed by +$314.00 K (+0.42%)
What is Relay Therapeutics TTM cash flow from operations?
The current TTM CFO of RLAY is -$280.43 M
What is the all time high TTM CFO for Relay Therapeutics?
Relay Therapeutics all-time high TTM cash flow from operations is -$10.82 M
What is Relay Therapeutics TTM CFO year-on-year change?
Over the past year, RLAY TTM cash flow from operations has changed by -$12.22 M (-4.56%)